FineMark National Bank & Trust grew its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 37.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,012 shares of the financial services provider’s stock after buying an additional 1,091 shares during the quarter. FineMark National Bank & Trust’s holdings in MetLife were worth $323,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Allworth Financial LP lifted its position in MetLife by 13.4% in the second quarter. Allworth Financial LP now owns 10,893 shares of the financial services provider’s stock worth $876,000 after purchasing an additional 1,285 shares during the period. Kathmere Capital Management LLC lifted its holdings in shares of MetLife by 88.2% in the second quarter. Kathmere Capital Management LLC now owns 6,328 shares of the financial services provider’s stock valued at $509,000 after buying an additional 2,965 shares during the period. Zurich Insurance Group Ltd FI bought a new position in MetLife during the first quarter valued at about $12,060,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in MetLife by 13.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,050,921 shares of the financial services provider’s stock worth $84,378,000 after acquiring an additional 123,947 shares during the period. Finally, GSA Capital Partners LLP raised its position in MetLife by 136.0% in the first quarter. GSA Capital Partners LLP now owns 14,721 shares of the financial services provider’s stock worth $1,182,000 after acquiring an additional 8,482 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
MET has been the subject of several research reports. Cowen restated a “buy” rating on shares of MetLife in a research report on Friday, August 22nd. Morgan Stanley increased their target price on shares of MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Jefferies Financial Group raised their target price on shares of MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a report on Monday, August 11th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of MetLife in a report on Monday. Finally, Wolfe Research raised MetLife to a “strong-buy” rating in a research note on Tuesday, September 16th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $95.00.
MetLife Price Performance
MET opened at $73.93 on Friday. The firm has a market capitalization of $48.71 billion, a P/E ratio of 12.53, a PEG ratio of 0.70 and a beta of 0.87. The stock has a fifty day moving average of $79.45 and a 200-day moving average of $78.88. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share for the quarter, beating the consensus estimate of $2.30 by $0.07. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The firm had revenue of $17.90 billion for the quarter, compared to analyst estimates of $18.64 billion. During the same period in the previous year, the firm earned $1.95 earnings per share. MetLife’s quarterly revenue was down 5.9% on a year-over-year basis. Equities analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be given a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend is Tuesday, November 4th. MetLife’s dividend payout ratio is 42.75%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
- Consumer Discretionary Stocks Explained
- Peter Thiel Dumps NVIDIA and Slashes Tesla Stake—Is the AI Bubble About to Pop?
- EV Stocks and How to Profit from Them
- Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
